Table 2.
Docking score of approved and investigational drugs.
| Drug Bank ID | Drug Name | Group | Category | Docking Score (kcal/mol) |
|---|---|---|---|---|
| DB08797 | Salicylamide | Approved | Analgesic | −7.10 |
| DB13026 | Ornidazole | Investigational | Antibiotic | −6.67 |
| DB14575 | Eslicarbazepine | Approved | Anticonvulsants. | −6.56 |
| DB14855 | 2-(aminomethyl)phenol | Investigational | Benzene Derivatives | −6.52 |
| DB13136 | Fluindione | Approved | Anticoagulants | −6.34 |
| DB04571 | Trioxsalen | Approved | Vitiligo | −6.34 |
| DB02262 | Orotic acid | Investigational | Pyrimidines | −6.29 |
| DB12155 | Napabucasin | Investigational | Anticancer | −6.25 |
| DB11836 | Sapanisertib | Investigational | Anticancer | −6.24 |
| DB12804 | Daniquidone | Investigational | Anticancer | −6.13 |
| DB00368 | Norepinephrine bitartrate | Approved | Cardiovascular agent | −6.12 |
| DB01424 | Aminophenazone | Approved; withdrawn | Analgesic | −6.10 |
| DB12827 | Indoximod | Investigational | Immunometabolic | −6.05 |
| DB06408 | Taribavirin Hydrochloride | Investigational | Antiviral | −6.03 |
| DB00480 | Lenalidomide | Approved | Anticancer | −5.99 |
| DB01033 | Mercaptopurine monohydrate | Approved | Anticancer | −5.99 |
| - | Z45617795 | - | Control 1 | −5.367 |
| - | Inhibitor N3 | - | Control 2 | −4.561 |